Author: Spectrum Science

Posted Date:

May 11, 2026

Apnimed Announces Three Oral Presentations and a Late-breaking Poster at the American Thoracic Society (ATS) 2026 International Conference

Spectrum Science

May 11, 2026
Spectrum Science Appoints Lisa Talbot to Lead Communications Business

Spectrum Science

April 16, 2026
Apnimed Secures Up to $150 Million in Debt Financing with HealthCare Royalty Partners to Support Planned AD109 Commercial Launch

Spectrum Science

April 6, 2026
Apnimed Announces Strategic Monetization of Shionogi-Apnimed Sleep Science (SASS) Joint Venture Stake for $150M and Royalties, Strengthening Focus on its Wholly-Owned OSA Program, AD109

Spectrum Science

March 24, 2026